Pilot Trial of the Effect of Vorinostat and AGS-004 on Persistent HIV-1 Infection
Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection
Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
A Phase I/II Study to Evaluate the Immunologic Response and Virologic Impact of AGS-004
† Study has passed its completion date and status has not been verified in more than two years.